Harnessing proteases for T regulatory cell immunotherapy.

Area of Science:

• Immunology
• Cell Biology
• Protease Biology

Background:

• Regulatory T cells (Tregs) are essential for maintaining immune homeostasis by suppressing excessive immune responses.
• The precise mechanisms controlling Treg function, particularly the role of proteases, are not fully understood.

Purpose of the Study:

• To review the critical role of proteases in regulating regulatory T cell (Treg) function.
• To explore the translational potential of targeting protease-driven pathways for Treg-based cellular therapeutics.

Main Methods:

• Review of existing literature on proteases implicated in Treg immunobiology, including furin, ADAM, MALT, and asparaginyl endopeptidase.
• Discussion of experimental evidence from protease inhibition studies and gene-deficient mouse models.
• Analysis of Treg cell engineering protocols incorporating protease targets.

Main Results:

• Specific proteases, such as furin and ADAM, are directly involved in Treg function and immunobiology.
• Targeted protease inhibition specifically modulates Treg function without affecting other T effector cells.
• Experimental models demonstrate the specificity and efficacy of protease modulation in controlling Treg activity.

Conclusions:

• Proteases represent a significant and underappreciated target for modulating Treg function.
• Harnessing protease-driven pathways in Treg cell engineering can lead to enhanced Treg cellular therapeutics.
• Engineered Tregs show potential for improved regulatory function and resistance to lineage deviation in inflammatory conditions like colitis and graft-versus-host disease.